The Value of Arginase-1 Immunohistochemical Stain in Differentiating Hepatocellular Carcinoma and Metastatic Pancreas Acinar Cell Carcinoma as Compared To Glypican-3

被引：0
|
作者：
Askan, Gokce
Shia, Jinru
Adsay, Volkan
Sigel, Carlie
Klimstra, David
Isik-Kaygusuz, Ecmel
Basturk, Olca
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Zeynep Kamil Hosp, Istanbul, Turkey
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1757
引用
收藏
页码：439A / 439A
页数：1
相关论文
共 50 条
  • [41] Arginase-1: A New Rabbit Monoclonal Antibody Is a Superior Marker in Differentiating Primary Hepatocellular Carcinoma vs. Tumors Metastatic to the Liver
    Sharma, B. K.
    Zhou, D.
    Bremer, R.
    Haas, T.
    Tacha, D.
    MODERN PATHOLOGY, 2013, 26 : 411A - 411A
  • [42] A CAR-T CELL THERAPY TARGETING GLYPICAN-3 POSITIVE HEPATOCELLULAR CARCINOMA
    Wang, B.
    Ngoh, E.
    Soh, M. K.
    Yeap, Y.
    Huang, H.
    Tan, H. C.
    Hu, Y.
    Wang, C. I.
    HUMAN GENE THERAPY, 2018, 29 (11) : A16 - A16
  • [43] Arginase-1: A New Rabbit Monoclonal Antibody Is a Superior Marker in Differentiating Primary Hepatocellular Carcinoma vs. Tumors Metastatic to the Liver
    Sharma, B. K.
    Zhou, D.
    Bremer, R.
    Haas, T.
    Tacha, D.
    LABORATORY INVESTIGATION, 2013, 93 : 411A - 411A
  • [44] Hep Par-1: A Novel Immunohistochemical Marker for Differentiating Hepatocellular Carcinoma from Metastatic Carcinoma
    Hanif, Razia
    Mansoor, Samina
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2014, 24 (03): : 186 - 189
  • [45] Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation
    Xiao Cui
    Zhao Li
    Peng-Ji Gao
    Jie Gao
    Ji-Ye Zhu
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (02) : 157 - 163
  • [46] Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation
    Cui, Xiao
    Li, Zhao
    Gao, Peng-Ji
    Gao, Jie
    Zhu, Ji-Ye
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 157 - 163
  • [47] Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients
    Mahmoud El-Bendary
    Khaled Farid
    Mohammad Arafa
    Wagdi Elkashef
    Talaat Abdullah
    Ahmed El-Mesery
    Journal of the Egyptian National Cancer Institute, 35
  • [48] Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients
    El-Bendary, Mahmoud
    Farid, Khaled
    Arafa, Mohammad
    Elkashef, Wagdi
    Abdullah, Talaat
    El-Mesery, Ahmed
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2023, 35 (01)
  • [49] T-CELL RE-DIRECTION AGAINST GLYPICAN-3 FOR IMMUNOTHERAPY OF HEPATOCELLULAR CARCINOMA (HCC)
    Dargel, C.
    Bassani-Sternberg, M.
    Wilde, S.
    Dossinger, G.
    Kerbs, K.
    Schiemann, M.
    Schendel, D.
    Busch, D. H.
    Mann, M.
    Protzer, U.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S40 - S40
  • [50] MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3
    Huang, Na
    Lin, Jing
    Ruan, Jian
    Su, Ning
    Qing, Ruzhai
    Liu, Feiye
    He, Benfu
    Lv, Chengwei
    Zheng, Dayong
    Luo, Rongcheng
    FEBS LETTERS, 2012, 586 (06) : 884 - 891
12345